ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $960,000 | +29.7% | 5,576 | -5.5% | 0.01% | +27.3% |
| Q2 2021 | $740,000 | -10.4% | 5,900 | -3.1% | 0.01% | -15.4% |
| Q1 2021 | $826,000 | +3.5% | 6,088 | -2.4% | 0.01% | 0.0% |
| Q4 2020 | $798,000 | +5.8% | 6,237 | -7.0% | 0.01% | -13.3% |
| Q3 2020 | $754,000 | +471.2% | 6,703 | +356.6% | 0.02% | +400.0% |
| Q1 2020 | $132,000 | +63.0% | 1,468 | -4.2% | 0.00% | +50.0% |
| Q4 2019 | $81,000 | +32.8% | 1,532 | -0.2% | 0.00% | +100.0% |
| Q3 2019 | $61,000 | -9.0% | 1,535 | -5.8% | 0.00% | 0.0% |
| Q2 2019 | $67,000 | -23.9% | 1,629 | -14.1% | 0.00% | -50.0% |
| Q1 2019 | $88,000 | -22.1% | 1,896 | -26.9% | 0.00% | -33.3% |
| Q4 2018 | $113,000 | +352.0% | 2,594 | +209.9% | 0.00% | +200.0% |
| Q2 2017 | $25,000 | +13.6% | 837 | -1.4% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | – | 849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |